Skip to content

An analysis of the use of microparasitic end-expiratory carbon dioxide monitoring during enteropharyngeal or nasopharyngeal airway placement for enteroscopic procedures in patients with obstructive sleep apnea syndrome

An analysis of the use of microparasitic end-expiratory carbon dioxide monitoring during enteropharyngeal or nasopharyngeal airway placement for enteroscopic procedures in patients with obstructive sleep apnea syndrome

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083702
Enrollment
Unknown
Registered
2024-04-30
Start date
2024-04-30
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive sleep apnea syndrome

Interventions

Studuy group: Intraoperative use of a single-use end-expiratory carbon dioxide collection nasal oxygen tube
Control:No Intraoperative use of a single-use end-expiratory carbon dioxide collection nasal oxygen tube

Sponsors

Affilated Chenggong Hospital of Xiamen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Confirm that the patient has been diagnosed with obstructive sleep apnea syndrome (OSAS), usually based on the diagnostic criteria of polysomnography or simplified sleep monitoring. The diagnostic criteria are usually based on polysomnography or simplified sleep monitoring. 2. Indication for colonoscopy: the patient requires colonoscopy and there is a clear medical necessity for the procedure. 3. the patient's OSAS is relatively stable, with no significant acute exacerbations or serious complications. 4. 4. Age range: 18-60 years old. 5. 5. no other medical or surgical diseases, ASA grade I-II.

Exclusion criteria

Exclusion criteria: 1. No apnea-sleep apnea syndrome 2. No indication for colonoscopy 3. Age less than 18 years old and more than 65 years old 4. Serious medical or surgical disease

Design outcomes

Primary

MeasureTime frame
Average carbon dioxide;Post-operative complications;

Secondary

MeasureTime frame
baseline vital signs; hospitalization;

Countries

China

Contacts

Public ContactShanshan Liu

Affilated Chenggong Hospital of Xiamen University

hanzhiluoluo@163.com+86 189 6581 0903

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026